Sarissa Capital Management LP

Position in BHVN — Biohaven Ltd.

CIK 1577524 GREENWICH, CT

Position in BHVN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$8,664,802

+$3,900,266 QoQ

Shares Held

582,312

+3.4% QoQ

Ownership

0.386%

of shares outstanding

% of Portfolio

4.87%

of 13F equity value

Holder Rank

#44

of 294 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Sarissa Capital Management LP holds $74,157,038 across 5 Biotechnology names. BHVN ranks #3 (11.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INVA	Innoviva, Inc.	1,890,604	$42,935,616
2	CYTK	Cytokinetics Inc	228,623	$19,476,393
3	BHVN	Biohaven Ltd. This page	582,312	$8,664,802
4	REGN	Regeneron Pharmaceuticals, Inc.	4,190	$2,612,632
5	VOR	Vor Biopharma Inc.	25,399	$467,595

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,664,802	582,312	+3.4%	Shares	Sole	2026-08-14
2026-03-31	$4,764,536	563,184	+9.7%	Shares	Sole	2026-05-15
2025-12-31	$5,793,847	513,184	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.